July 30, 2018 — The U.S. Food and Drug Administration today approved Azedra (iobenguane I 131) injection for intravenous use for the treatment of adults and adolescents age 12 and older with rare tumors of the adrenal gland (pheochromocytoma or…Original Article
FDA Approves Azedra (iobenguane I 131) for Rare Adrenal Tumors
